CLPBF (Coloplast AS) OCF Margin %: 20.69% (As of Mar. 2026) — 11% Below Median


CLPBF Coloplast AS CLPBF
72 GF Score
Price $57.41
GF Value $126.91
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Coloplast AS OCF Margin %?

Coloplast AS CLPBF 72 OCF Margin % is 20.69% as of Mar. 2026, which is 11% below its 10-year median of 23.21. GuruFocus rates CLPBF with a GF Score™ of 72/100 and a GF Value™ of $126.91 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Coloplast AS ranks better than 89.69% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Coloplast AS's Cash Flow from Operations for the three months ended in Mar. 2026 was $227 Mil. Coloplast AS's Revenue for the three months ended in Mar. 2026 was $1,096 Mil. Therefore, Coloplast AS's OCF Margin % for the quarter that ended in Mar. 2026 was 20.69%.

As of today, Coloplast AS's current OCF Yield % is 9.12%.

The historical rank and industry rank for Coloplast AS's OCF Margin % or its related term are showing as below:

CLPBF' s OCF Margin % Range Over the Past 10 Years
Min: 10.23   Med: 23.21   Max: 27.23
Current: 27.12


During the past 13 years, the highest OCF Margin % of Coloplast AS was 27.23%. The lowest was 10.23%. And the median was 23.21%.

CLPBF's OCF Margin % is ranked better than
89.69% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: 5.86 vs CLPBF: 27.12


Coloplast AS OCF Margin % Related Terms


Coloplast AS OCF Margin % Historical Data

* Premium members only.

The historical data trend for Coloplast AS's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coloplast AS OCF Margin % Chart

Coloplast AS Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.23 22.58 17.25 10.23 23.84

Coloplast AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.71 23.44 32.54 31.71 20.69

CLPBF vs ISRG, BDX, MDLN: OCF Margin % Comparison

For the Medical Instruments & Supplies subindustry, Coloplast AS's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast AS OCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast AS's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Coloplast AS's OCF Margin % falls into.


CLPBF
72GF Score
Coloplast AS CLPBF
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Coloplast AS OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Coloplast AS's OCF Margin for the fiscal year that ended in Sep. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Sep. 2025 )/Revenue (A: Sep. 2025 )
=1044.976/4383.394
=23.84 %

Coloplast AS's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=226.749/1095.695
=20.69 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 20.69% mean?
Coloplast AS (CLPBF) has a OCF Margin % of 20.69% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Coloplast AS and its competitors. This is 11% below median its historical median of 23.21. Over the past decade, Coloplast AS's OCF Margin % has ranged from 10.23 to 27.23. According to the industry distribution chart, Coloplast AS ranks #84 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 10.3%.
Is Coloplast AS's OCF Margin % too high?
Coloplast AS's current OCF Margin % of 20.69% is 11% below median its 10-year median of 23.21. Over the past 10 years, this metric has ranged from a low of 10.23 to a high of 27.23. The Medical Devices & Instruments industry median OCF Margin % is 5.86. Coloplast AS's value of 20.69% is 253.1% above this industry median. Based on the distribution chart, Coloplast AS ranks #84 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Coloplast AS has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Coloplast AS's OCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Coloplast AS ranks #84 out of 815 companies for OCF Margin %. This places Coloplast AS in the top 10% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 5.86. Coloplast AS's value of 20.69% is 253.1% above this benchmark. Historically, Coloplast AS's own OCF Margin % has ranged from 10.23 to 27.23 over the past decade. While the company's 10-year median is 23.21 vs. the industry median of 5.86, Coloplast AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Coloplast AS's current OCF Margin % of 20.69% is 253.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Coloplast AS and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Coloplast AS's current OCF Margin % is 20.69%, which is 11% below median its own 10-year median of 23.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coloplast AS stock overvalued right now?
Based on GuruFocus' analysis, Coloplast AS (CLPBF) is currently considered Significantly Undervalued. The stock's GF Value™ is $126.91, compared to a current price of $57.41 — trading 54.8% below its estimated fair value. The current OCF Margin % is 20.69%, which is 11% below median its 10-year median of 23.21 and 253.1% above the Medical Devices & Instruments industry median of 5.86. Coloplast AS's overall GF Score™ is 72/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Coloplast AS (CLPBF), the current OCF Margin % is 20.69% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Coloplast AS (CLPBF) Overvalued in 2026?

Based on GuruFocus' analysis, Coloplast AS stock appears to be undervalued. The current stock price of $57.41 is trading 54.8% below its estimated GF Value™ of $126.91. GuruFocus considers Coloplast AS to be Significantly Undervalued.

Key valuation signals for CLPBF:

  • OCF Margin %: 20.69% (11% below median its 10-year median of 23.21)
  • GF Value™: $126.91 vs. price of $57.41 (54.8% below fair value)
  • GF Score™: 72/100 with 7 warning signs
  • Industry Position: 253.1% above the Medical Devices & Instruments median (#84 of 815)

No single metric tells the full story. See the CLPBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Coloplast AS Business Description

Address Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, intermittent catheters for continence care, and devices for patients with neck stomas. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.
72GF Score

Get the complete analysis for CLPBF

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$57.41
Price
$126.91
GF Value